Please ensure Javascript is enabled for purposes of website accessibility

Targeted Radiopharmaceuticals Summit is approaching: Μeet BIOEMTECH, a new, exponentially growing CRO!

In November 24, 2022
On 2022

Our CEO George Loudos, our Lab Director Maritina G. Rouchota and our R&D and Q&A Manager Theodoros Karampelas will be in Amsterdam, looking forward to discussing with you about our unique services and tools for preclinical studying and imaging of therapeutic radionuclides. You can – Meet us in person at our booth and you will be impressed from our capabilities and rich portfolio .Attend our talk “Successful Real-Time In Vivo Imaging of Pb-212 and Ac-225 in Preclinical Oncological Models” on December 7th – Visit our poster, where we present selected results from studies in oncological and other preclinical models (https://lnkd.in/dj5ARQNd). We look forward to seeing in person many of our collaborators and present our expertise to groups that we have not worked together yet!

Share
Tweet